Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anne Bellon

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Journal of Thrombosis and Haemostasis : JTH|January 21, 2019
Clinical pharmacology, efficacy and safety study of a triple-secured fibrinogen concentrate in adults and adolescent patients with congenital fibrinogen deficiencyClaudia Djambas Khayat, Mohamed El Khorassani, Thierry Lambert, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|May 17, 2017
Biological Safety of a Highly Purified 10% Liquid Intravenous Immunoglobulin Preparation from Human PlasmaCaroline Goussen, Steve Simoneau, Soline Bérend, et al.
Current Medical Research and Opinion|April 8, 2022
A review of the totality of evidence supporting the development and approval of a pegfilgrastim biosimilar (LA-EP2006)Sanjiv S Agarwala, Ulrich Nagl, Xinghua Guo, et al.
Transfusion|September 17, 2013
Decontamination of prions in a plasma product manufacturing environmentAnne Bellon, Emmanuel Comoy, Steve Simoneau, et al.
Plos One|December 9, 2008
The POM monoclonals: a comprehensive set of antibodies to non-overlapping prion protein epitopesMagdalini Polymenidou, Rita Moos, Mike Scott, et al.
British Journal of Clinical Pharmacology|February 6, 2020
A large multicentre, randomized, double-blind, cross-over study in healthy volunteers to compare pharmacokinetics, pharmacodynamics and safety of a pegfilgrastim biosimilar with its US- and EU-reference biologicsAnne Bellon, Jessie Wang, Andrej Skerjanec, et al.
European Journal of Cancer (Oxford, England : 1990)|May 22, 2026
Debio 0123, a WEE1 kinase inhibitor: Phase 1 results from dose escalation in patients with advanced solid tumorsKyriakos P Papadopoulos, Manish R Sharma, Reinhard Dummer, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Journal of Thrombosis and Haemostasis : JTH|January 21, 2019
Clinical pharmacology, efficacy and safety study of a triple-secured fibrinogen concentrate in adults and adolescent patients with congenital fibrinogen deficiencyClaudia Djambas Khayat, Mohamed El Khorassani, Thierry Lambert, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|May 17, 2017
Biological Safety of a Highly Purified 10% Liquid Intravenous Immunoglobulin Preparation from Human PlasmaCaroline Goussen, Steve Simoneau, Soline Bérend, et al.
Current Medical Research and Opinion|April 8, 2022
A review of the totality of evidence supporting the development and approval of a pegfilgrastim biosimilar (LA-EP2006)Sanjiv S Agarwala, Ulrich Nagl, Xinghua Guo, et al.
Transfusion|September 17, 2013
Decontamination of prions in a plasma product manufacturing environmentAnne Bellon, Emmanuel Comoy, Steve Simoneau, et al.
Plos One|December 9, 2008
The POM monoclonals: a comprehensive set of antibodies to non-overlapping prion protein epitopesMagdalini Polymenidou, Rita Moos, Mike Scott, et al.
British Journal of Clinical Pharmacology|February 6, 2020
A large multicentre, randomized, double-blind, cross-over study in healthy volunteers to compare pharmacokinetics, pharmacodynamics and safety of a pegfilgrastim biosimilar with its US- and EU-reference biologicsAnne Bellon, Jessie Wang, Andrej Skerjanec, et al.
European Journal of Cancer (Oxford, England : 1990)|May 22, 2026
Debio 0123, a WEE1 kinase inhibitor: Phase 1 results from dose escalation in patients with advanced solid tumorsKyriakos P Papadopoulos, Manish R Sharma, Reinhard Dummer, et al.
Pageof 2